Immunicum’s abstract with data from a kidney cancer study

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Immunicum’s abstract with data from a kidney cancer study has been approved for presentation at the 2014 ASCO Annual Meeting in Chicago

Göteborg, Sweden, 2014-03-27 10:25 CET (GLOBE NEWSWIRE) -- Immunicum today announced that an abstract has been approved to for presentation at the American Society of Clinical Oncology’s’s, ASCO, annual convention held in Chicago May 30-June 3, 2014.

The abstract, with title “ Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diagnosed metastatic renal cell carcinoma (mRCC)”, presents clinical data from the newly finalized phase I/II-study on kidney cancer patients treated with INTUVAX®.

-       Being accepted to present at the most prestigious cancer conference in the world creates a great opportunity for us to showcase Immunicum’s technology and shows the level of scientific interest our clinical data has generated, says Immunicum’s CEO, Jamal El-Mosleh.

Immunicum recently received the results of the data for the phase I/II In trial in patients with metastatic renal cell carcinoma (mRCC)”

”We are pleased to report conclusions that can be crucial for the survival time in patients with mRCC” says Jamal El-Mosleh, the CEO of Immunicum.

During the ASCO annual meeting more data is to be presented to the meeting participants and the media.

Immunicum’s immunotherapy plattforms are based on over 30 years of research in the field of transplantation immunology. The Company’s shares have been traded since April 22, 2013 on NASDAQ OMX First North under the ticker IMMU.

For further information please contact:

Jamal El-Mosleh, CEO of Immunicum, +4631-41 50 53, jamal.el-mosleh@immunicum.com

Redeye AB is chosen as the Company’s Certified Adviser.

Tel: +468-545 013 31. www.redeye.se .

About Immunicum AB (publ):

Immunicum AB (publ) develops cancer immunotherapies. Its two main groups of therapeutic cancer vaccines, SUBCUVAX ® and INTUVAX ® , and the method of expansion of tumor-specific T-cells (CD70) is based on the Nobel prize awarded discovery of the dendritic cell and its central role in the activation of the specific immune response. Since the raw material consists of allogeneic dendritic cells, Immunicum’s products can be produced in large scale. The vaccines are now undergoing clinical trials in renal cell carcinoma and hepatocellular carcinoma.  

www.immunicum.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating Cigar Choices for Every Event: Expert Tips

Updated Category News Views 88

A Smoke for Every Social Scene Did you ever think picking cigars for an event could feel like juggling cats? Well, according to Mike Glynn, navigating this hazy territory is all about balance. Whether it's catering to seasoned smoke connoisseurs or newcomers likely to inhale the wrong end, Glynn's insights show how to strike that equilibrium without a hitch. Medium-Bodied...

Continue Reading
Ajman Media Forum 2026: Shaping the Future of Media

Updated Category News Views 46

Kicking Off Ajman's Media Innovation Push Forget the stale conferences; Ajman is putting its chips on the table with the inaugural Ajman Media Forum 2026. Set to ignite on November 18 and 19 under the catchy theme 'Who Owns the Signal?,' this two-day brain fest takes media transformation by the horns. They're not just talking; they're set to weave emerging tech,...

Continue Reading
Senstar Boasts Robust Q3 Growth Amid Global Demand

Updated Category News Views 19

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

Continue Reading
Faith Leaders Reject Dominion-NextEra $67B Merger

Updated Category News Views 108

Voices Raised Against a Corporate Giant Today, outside the drab halls of the Virginia State Corporation Commission (SCC), a group of faith leaders drew a line in the sand against a looming energy giant. The $67 billion move to merge Dominion Energy with NextEra Energy ignited their rallying cry. Phooey to sacrificing community well-being for corporate greed, they shouted....

Continue Reading
Vaudit Welcomes Industry Veteran David Coleman

Updated Category News Views 104

David Coleman: Vaudit's New Ad Chief David Coleman stepping into Vaudit's spotlight as President of Advertising Industry is a twist worth watching. Vaudit, for those not up to speed, is an AI-driven powerhouse that keeps vendors in line with what they're charging. And let me tell you, Coleman's kind of heavy-hitter leadership doesn't come cheap, nor does it play nice with...

Continue Reading
Thryfter Unleashes Livestream Magic at Goodwill Event

Updated Category News Views 83

A Dynamic Shift in Thrift Shopping All eyes might be on Thryfter this November as they drop some serious retail knowledge at the Goodwill CONNECT Conference in Houston. We’re talking about a tech shake-up for Goodwill’s model, thanks to Thryfter's livestream shopping craze that’s poised to weld traditional thrifting with digital reach. The Power of Virtual Thrift...

Continue Reading
Datavations Unveils Test Tracker for Home Improvement

Updated Category News Views 41

Unearthing the Strategic Gold Datavations has launched something that could be a real game-changer for home improvement suppliers—a tool called the Store Test Tracker. This thing zeros in on limited-distribution SKU tests happening in the giant playgrounds of Home Depot, Lowe's, and Menards. You think small-scale trials don't matter? Buckle up, because sometimes the...

Continue Reading
Silvercorp Navigates Q2 with Strategic Resilience

Updated Category News Views 62

Silvercorp's Q2: A Mixed Bag of Gains and Strains Coming in hot this November, Silvercorp swings between highs and lows for Q2 Fiscal 2027. They reported a not-too-shabby adjusted net income of $18.4 million—or $0.08 a pop per share. No one's throwing a parade for that, but it's stable sailing amidst some choppy waters. Safety Comes with a Price Safety upgrades have...

Continue Reading
AgriBank's Q3 Performance Shows Solid Growth in 2026

Updated Category News Views 103

AgriBank's Third Quarter Triumph Let me tell you, the folks at AgriBank have reason to crack open some celebratory cider this quarter. They're sitting pretty with a robust third quarter, reporting a net income of $910.9 million for the first nine months of 2026. That's no small potatoes, especially when you're surpassing targets like their 58 basis points return on...

Continue Reading
4,000 Fans Flock to GOD WITH US Premiere Event

Updated Category News Views 75

Massive Turnout for GOD WITH US Premiere Tell ya what, the film industry's seen something special with GOD WITH US. More than 4,000 movie buffs crammed into its premiere, showing that when a story hits home, folks are all in. This modern-day parable has locked in a following before its wider release, set to hit select theaters on November 13. It’s a move from Blue...

Continue Reading

Top 5 Most Recently Viewed Articles

Air France-KLM's Strong Performance Insight for 2024

Updated Category News Views 719

Air France-KLM: An Overview of Full Year 2024 Results Air France-KLM has recently shared its full-year performance for 2024, demonstrating resilience and growth despite global challenges. Analyzing this year's results reveals exciting insights into the airline industry, showcasing how Air France-KLM has adapted and thrived. Financial Highlights of 2024 The financial...

Continue Reading
Transforming a $1000 Investment in EQT: What It Could Be Today

Updated Category News Views 378

Understanding EQT's Growth Over Two Decades EQT has demonstrated impressive performance in the market over the last 20 years, consistently outperforming many expectations. Over this period, it has yielded an exceptional average annual return of 18.18%, surpassing the broader market by 9.62%. With a current market capitalization of approximately $33.30 billion, EQT stands...

Continue Reading
Man Group PLC Updates on Dowlais Group plc Stake Holding

Updated Category News Views 126

Overview of Man Group PLC's Interests Man Group PLC, a prominent player in the investment management industry, has recently disclosed extensive details regarding its interests in Dowlais Group plc. This disclosure, required under Rule 8.3 of the Takeover Code, highlights significant stakes in relevant securities, showcasing the company's strategic involvement in the...

Continue Reading
Maritime Patrol Aircraft Market Insights: Growth and Trends

Updated Category News Views 268

Discover the Dynamics of the Maritime Patrol Aircraft Market The maritime patrol aircraft market is on an impressive trajectory, with expectations to increase from USD 6.7 billion to USD 11.9 billion within just five years. This remarkable growth, projected at a CAGR of 12.1%, signals a robust demand for enhanced surveillance and reconnaissance capabilities among global...

Continue Reading
LHV Group's Recent Share Acquisitions Highlight Growth Strategy

Updated Category News Views 207

LHV Group's Commitment to Share Acquisition LHV Group has announced its recent transactions involving the acquisition of its own shares on the Nasdaq Tallinn Stock Exchange, showcasing its dedication to enhancing shareholder value. This significant step is part of LHV Group's broader financial strategy aimed at bolstering its market presence and aligning with shareholder...

Continue Reading